Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nuclear protein 1 is a cell death regulator in primary human airway epithelial cells and reduced in idiopathic pulmonary fibrosis.

Scientific reports·2026
Same author

The pleuroparenchymal fibroelastosis atlas reveals aberrant cell states and their zonation as an alternate roadmap to lung fibrosis.

Science advances·2026
Same author

Clonal Hematopoiesis Instructs Maladaptive Tissue Repair to Promote Fibrosis.

bioRxiv : the preprint server for biology·2026
Same author

Spatial transcriptomics uncovers hybrid, proinflammatory, and profibrotic cellular niches in pulmonary granuloma of patients with chronic sarcoidosis.

American journal of respiratory and critical care medicine·2026
Same author

Prognostic biomarkers for idiopathic pulmonary fibrosis: findings from ISABELA clinical trials.

ERJ open research·2026
Same author

Sex Differences in IPF: Data from the German INSIGHTS Registry.

Respiration; international review of thoracic diseases·2026

Related Experiment Video

Updated: Jul 10, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Phenotyping sarcoidosis from a pulmonary perspective.

Antje Prasse1, Christine Katic, Martin Germann

  • 1Abteilung für Pneumologie, Universitätsklinik Freiburg, Killianstr. 5, 79106 Freiburg, Germany. antje.prasse@uniklinik-freiburg.de.

American Journal of Respiratory and Critical Care Medicine
|November 3, 2007
PubMed
Summary

A new clinical classification system for sarcoidosis, the SCAC protocol, effectively stratifies patients by disease outcome and aids in evaluating biomarkers and genetic markers for better treatment decisions.

More Related Videos

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Related Experiment Videos

Last Updated: Jul 10, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Area of Science:

  • Pulmonology
  • Immunology
  • Clinical Medicine

Background:

  • Sarcoidosis exhibits significant heterogeneity in clinical severity and inflammatory activity.
  • Current radiologic classification systems are insufficient for guiding clinical decisions.
  • There is a critical need for biomarkers and genetic markers to predict sarcoidosis outcomes.

Purpose of the Study:

  • To develop a clinical classification system for sarcoidosis to facilitate the evaluation of biomarkers and genetic markers.
  • To establish a practical protocol for stratifying sarcoidosis based on clinical criteria.

Main Methods:

  • A protocol for sarcoidosis classification (SCAC) was developed based on three clinical criteria: onset (acute/nonacute), treatment requirement, and long-term treatment need.
  • The SCAC protocol and a radiologic classification system were retrospectively applied to 225 sarcoidosis patients.

Main Results:

  • The SCAC protocol successfully stratified patients based on disease outcome.
  • Significant differences in pulmonary function and bronchoalveolar lavage cell composition were observed between chronic sarcoidosis classes.
  • Elevated soluble IL-2 receptor and neopterin levels were associated with acute disease requiring long-term treatment and nonacute disease needing long-term treatment.

Conclusions:

  • The SCAC protocol is a practical tool providing valuable clinical information beyond radiologic typing.
  • The SCAC system is suitable for research evaluating genetic influences and biomarkers in sarcoidosis.
  • This clinical classification aids in understanding disease heterogeneity and predicting outcomes.